To investigate the expression of multidrug-resistant ATP binding cassette transporter Pglycoprotein (MDR1/ABCB1/P-gp) in mastitis and its correlation with the expression of apoptosis regulation. Methods: Mastitic and normal mammary gland samples were collected after clinical examination and confirmed using field California mastitis test. Total RNA was extracted followed by cDNA synthesis and real-time PCR to detect the expression pattern of P-gp. Tissue sections were examined for pathological changes and immune reactivity to the apoptotic regulator, Bcl-2-associated X protein (BAX). Results: Stained sections from mastitic samples showed congestion, infiltration of inflammatory cells and hemorrhage. Using immunohistochemistry, it was shown that mastitis is associated with overexpression of the apoptosis regulator, Bcl-2-associated X protein (BAX). There was increased expression of the pro-apoptotic factor, Bax, in mastitic alveolar lining and lactic tubules compared with normal mammary gland tissues. Using real-time PCR, the expression level of MDR1/ABCB1 was determined to be 2.6-fold higher in mastitic tissues than in normal mammary tissues.
INTRODUCTION
ATP-binding cassette drug transporters (ABC transporters) comprise of a large set of proteins that are bound to cell membranes [1] . These proteins are ubiquitous and present in lower prokaryotes as well as in eukaryotes. ABC transporters can be classified into importers or effluxers. The importers transport nutrients and other water-soluble molecules into the cells and are present only in prokaryotes, while effluxers or exporters expel the compounds to outside the cells and are present in both prokaryotes and eukaryotes [2] .
Among the exporters, the multidrug resistant ABCB1 transporter, which is also known as Pglycoprotein (P-gp), is associated with multidrug resistance in cancers and microbial diseases [3] . P-gp expression was found to increase in multidrug resistant parasites such as leishmania [4] , onchocerca [5] , Plasmodium [6] and other parasites [7] . Furthermore, P-gp is associated with multidrug resistance in cancer cells and leads to failure of treatment due to lack of drug concentration inside cancer cells due to over-expression of P-gp [8] . The increased level of expression of P-gp was shown to correlate with insensitivity to the effect of drugs such as ivermectin and other macrocyclic lactones [9] [10] [11] .
ABC transporters are membrane bound proteins ( Figure 1 ) composed of several domain comprising six transmembrane domains and ATP binding intracellular domains. The ATP binding domain catalyzes ATP hydrolysis during export of the substrates. During their activity in exporting the drug molecules to outside the cell, ATP is consumed, and ADP is released [12] . The wide variety of ABC transporters is attributed corrected to the membrane spanning domains, which evolved independent of the ATP domain [2] . ABC transporters change between two conformations called inward-outward open conformations. For exporting molecules, the substrate affinity is higher in the inward conformation
and decreases the open conformation. After binding with the inwardshaped ABC transporter, the ATP binding domains interact and induce conformational changes that lead to outward opening of transmembrane domain and expulsion of substrates to outside the cells [13, 14] .
The term binding cassette refers to the interaction of the two ATP binding domains with ATP position at the interface between these two domains ( Figure 1 ). Each of the two ATP binding domains have a cavity to fit 1 ATP molecule. During efflux of substances, the two domains move to get in contact with each other at their ATP binding sites. Thus, the two ATP molecules appear to be sandwiched between the A domains of ABC transporters [15, 16] . The substrate translocates to a certain path within Pgp across its transmembrane domains to be exported to outside the cells ( Figure 1 ).
Mastitis includes complex interactions and releases inflammatory mediators. MDR1/ABCB1
is a part of body defense mechanism to protect cells from damage by deleterious agents and exogenous toxins. Because mastitis is a common problem in veterinary field with an economic impact, the understanding of expression profile of MDR1/ABCB1 in udder affections needs to be significantly improved. Changes in MDR1/ABCB1 expression level are expected to modulate the concentrations of intracellular signaling molecules and chemotherapeutic agents. In this study, the expression of MDR1/ABCB1 in normal and mastitic bovine udders and its associated pathological aspects and expression of pro-apoptotic factors were investigated. 
EXPERIMENTAL

Collection of samples and experimental design
Tissue samples from the mammary gland of Holestein cows were collected from Alomran abattoir in Alahsa, Saudi Arabia. In total, 20 samples (10 normal and 10 mastitic cows) were collected. History was acquired for every sample to check the reason of culling. Before slaughter, milk samples were collected from udders and checked using the California mastitis test (CMT [17] .
Sequence retrieval and design of P-gp real time primers
The sequence of P-gp (accession no. AY789648) was retrieved from GenBank. P-gp was obtained using a pair of primers: forward primer 5`-CGATGGCAAGGAAATAAAGCAGCTGA-3` and reverse primer 5`-GGCTGTTGTCTCCGTAGGC GATGTTC-3`. The primers were purified via HPLC to ensure maximum quality (Macrogen Inc., South Korea).
RNA extraction
Total RNA was extracted from tissue samples using the total RNA extraction kit (Qiagen Inc., USA) according to manufacturer instructions. The extracted RNA concentration was assessed using a spectrophotometric method.
Production of cDNA
cDNA was produced from total RNA using the cDNA synthesis kit (Invitrogen, CA, USA). First, RNA was incubated with BSA (1 mg/mL), RT primer and RNase-free water in a total volume of 6.0 μL. The mixture was incubated at 65°C for 5 min. Then, 4 μL of the second mixture containing Super Script TM III Reverse Transcriptase, DTT and RNase inhibitor was added, and incubation was continued at 55 °C for 1 h. The cDNA synthesis was stopped by incubation at 70°C for 5 min. cDNA was quantified using the spectrophotometric method.
Real time PCR
The produced cDNA was used as a template to quantify the amount of the produced P-gp in udder tissues. The real time mixture contained 10 μL of the 2x SYBR green master mix (Qiagen Inc., USA), 0.5 μL of cDNA, 2 μL of each primer (pmol) and RNase-free water up to 20 μL. Cycling conditions included denaturation for 8 min at 95 °C, followed by 40 amplification cycles: 10 s denaturation at 95 °C, 30 s annealing at 57 °C, and 10 s extension at 72 °C. Quantitation was based on relative levels in comparison with glyceraldehyde-3-phosphate dehydrogenase (GADPH), as described previously [18] . The reaction was carried out in BioRad CFX96 Touch real time detection system. The analysis of mRNA expression data was performed using the CFX manager 3.1 software. Cycle threshold (CT) was used to compare MDR1 expression.
Histopathology and immunohistochemistry (IHC)
Fixed tissue samples were dehydrated and embedded in paraffin wax. Five µm sections were stained with H&E. IHC was performed using streptavidin-biotin immunoperoxidase method.
First, tissue sections were deparaffinized and rehydrated followed by microwave exposure of antigens. 1% hydrogen peroxide was added, and the samples were incubated for 15 min to reduce the background and nonspecific staining due to endogenous peroxidase. Nonspecific staining was blocked using Ultra V block (Thermo Fisher, USA). Tissues were incubated with Bax primary antibody for antigen antibody reactions. Biotinylated goat anti-polyvalent antibody and streptavidin peroxidase were applied sequentially. 3·3'-diaminobenzidine peroxidase compatible chromogen was applied for detection. Then, the sections were counterstained with hematoxylin, dehydrated, and mounted. Negative control was produced using non-immune serum instead of reactive antibodies.
RESULTS
Clinical and gross pathological findings
Clinical exam of mastitic udder detected swelling, firmness and tenderness in the affected quarter. Cheesy or discolored fluid oozed from the lactiferous duct during sampling of mastitic udder. Highly reactive to CMT samples were considered as positive samples.
Pathological examination
Samples from positive clinical and CMT tests as well as normal udder samples were stained with H&E to confirm the status of udder before gene expression profiling of MDR1/ABCB1. The normal mammary gland tissue showed intact mammary alveoli and ducts and healthy interstitial blood vessels. Mastitic samples showed congested apparently dilated interstitial blood vessels, multiple areas of interstitial hemorrhage and cellular infiltration (Figure 2) . In most of the examined sections, bacterial clumps, mostly cocci, were detected. The alveolar epithelium showed degeneration and sloughing. The interlobular tissue was swollen with hyperemic blood vessels. Occasionally, inflammatory cells, including mononuclear cells and leucocytes, were observed. 
Gene expression of P-gp MDR1/ABCB1
mRNA expression level of P-gp MDR1/ABCB1 in normal and mastitic tissues was measured using real time PCR. The expression level was normalized to the reference gene GADPH. The estimated levels were 0.23 ± 0.09 and 0.62 ± 0.18 for normal and mastitic samples, respectively. This indicates a 2.6-fold increase in the expression level of P-gp MDR1/ABCB1 in mastitic udder.
Expression of pro-apoptotic factor, Bax
The positive immune reactivity for Bax was identified by the presence of faint brown color in the lining of mammary gland alveoli and ductioles (Figure 3 ). 
DISCUSSION
Multidrug resistant ABC transporter is primarily composed of one monomer composed of two sets of transmembrane domains and two ATP binding domains. Drug resistance in cancers has been associated with expression of P-gp. Reversal of P-gp activity by inhibitors is a new strategy to minimize drug resistance [19] . ABC transporters have ability to export a wide range of hydrophilic and hydrophobic substances. Pglycoprotein forms V-shaped open conformation toward the inner site of the cell. Thus, this allows hydrophilic materials to be trapped directly in the active binding site. In addition, there is a gap in ABC transporters at their membrane site to allow hydrophobic substances to be trapped directly in the active site [20, 21] .
During mastitis, several interactive mediators are released that can modify a wide range of cellular proteins and membrane transporters. These changes have significant impact on drug disposition kinetics [22] . The overexpression of P-gp in mastitic tissue is expected to increase the efflux of drug to outside the udder cells and modulate their effect by increasing their extracellular concentration.
Apoptosis includes a series of complex interactions between cellular components and signaling molecules. The increased expression of pro-apoptotic factor Bax indicates increased apoptosis in mammary gland cells. Upregulation of Bax expression has been associated with programmed cell death of mouse mammary gland involution [23] . Bax accumulation precedes the activation of the apoptotic precursor Caspase-3 [24] .
Positive Bax staining was detected in the alveoli and ductioles of the mammary gland. This agrees with the previous finding of Bax expression profile in bovine mammary gland [25] . Therefore, both pro-apoptotic markers and drug resistance exporters are upregulated in mastitis. Mastitic udder cells show higher expression of Pgp MDR1/ABCB1. This may be a protective mechanism, which is characterized by pumping toxins and signaling mediators to outside the cells.
CONCLUSION
Mastitis is associated with a complex expression profile of mediators and proteins. Upregulation of P-gp MDR1/ABCB1 in mastitis may be a part of a protective defense mechanism. Over-expression of P-gp MDR1/ABCB1 has been associated with the apoptotic regulator, Bax. Higher Bax levels may induce the overexpression of P-gp to protect the cells from toxic chemicals and inflammatory mediators that are released during inflammation.
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